Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label studyXiaoning Wu, Hong You, Hongxin Piao et al.|Expert Opinion on Biological Therapy|2018Cited by 44
On‐treatment changes of liver stiffness at week 26 could predict 2‐year clinical outcomes in <scp>HBV</scp>‐related compensated cirrhosisShanshan Wu, Jidong Jia, Yuanyuan Kong et al.|Liver International|2017Cited by 41